TREATMENT SET TS339754 injection, solution
TREATMENT SET TS340054 injection, solution
TREATMENT SET TS339813 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts339754 injection, solution treatment set ts340054 injection, solution treatment set ts339813 injection, soluti

antigen laboratories, inc. - felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), sorghum halepense pollen (unii: 577va5b4hp) (sorghum halepense pollen - unii:577va5b4hp), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk), betula populifolia pollen (unii: 23h70fyj5u) (betula populifolia pollen - unii:23h70 - felis catus hair 16 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS337554 injection, solution
TREATMENT SET TS337681 injection, solution
TREATMENT SET TS338384 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts337554 injection, solution treatment set ts337681 injection, solution treatment set ts338384 injection, soluti

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), quercus alba pollen (unii: z4y9zsv4kk) (quercus alba pollen - unii:z4y9zsv4kk) - dermatophagoides pteronyssinus 2000 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS347745 injection, solution
TREATMENT SET TS347746 injection, solution
TREAMTENT SET TS347738 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts347745 injection, solution treatment set ts347746 injection, solution treamtent set ts347738 injection, soluti

antigen laboratories, inc. - plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), chenopodium album pollen (unii: 098lkx5ncn) (chenopodium album pollen - unii:098lkx5ncn), urtica dioica pollen (unii: dnb59m1nvu) (urtica dioica pollen - unii:dnb59m1nvu), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), rumex acetosella pollen (unii: n52miq81 - plantago lanceolata pollen 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS340074 injection, solution
TREATMENT SET TS340153 injection, solution
TREATMENT SET TS340525 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts340074 injection, solution treatment set ts340153 injection, solution treatment set ts340525 injection, soluti

antigen laboratories, inc. - felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), carya alba pollen (unii: g2a764t54b) (carya tomentosa pollen - unii:g2a764t54b), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pte - felis catus hair 400 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS337026 injection, solution
TREATMENT SET TS336851 injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts337026 injection, solution treatment set ts336851 injection, solution

antigen laboratories, inc. - canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), gallus gallus feather (unii: 1fcm - canis lupus familiaris hair 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS338618 injection, solution
TREATMENT SET TS338909 injection, solution
TREATMENT SET TS338910 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts338618 injection, solution treatment set ts338909 injection, solution treatment set ts338910 injection, soluti

antigen laboratories, inc. - felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), iva annua var. annua pollen (unii: y2u5s5pf22) (iva annua var. annua pollen - unii:y2u5s5pf22), fraxinus americana pollen (unii: g684lx721q) (fraxinus ameri - felis catus hair 2000 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS344558 injection, solution
TREATMENT SET TS344570 injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts344558 injection, solution treatment set ts344570 injection, solution

antigen laboratories, inc. - cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), aureobasidium pullulans var. pullutans (unii: d1a2ng69ck) (aureobasidium pullulans var. pullutans - unii:d1a2ng69ck), fusarium oxysporum (unii: 5398rxp8ku) (fusarium oxysporum - unii:5398rxp8ku), penicillium chrysogenum var. chrysogenum (unii: - cladosporium cladosporioides 0.00008 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS345463 injection, solution
TREATMENT SET TS345476 injection, solution
TREATMENT SET TS345694 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts345463 injection, solution treatment set ts345476 injection, solution treatment set ts345694 injection, soluti

antigen laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), carya illinoinensis pollen (unii: pyo4jr720y) (carya illinoinensis pollen - unii:pyo4jr720y), carya tomentosa pollen (unii: g2a764t54b) (carya tomentosa pollen - unii:g2a764t54b), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), rumex acetosella pollen (unii: n52miq - cynodon dactylon pollen 16 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS348237 injection, solution
TREATMENT SET TS348283 injection, solution
TREATMENT SET TS348334 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts348237 injection, solution treatment set ts348283 injection, solution treatment set ts348334 injection, soluti

antigen laboratories, inc. - amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), avena sativa pollen (unii: a7iky24tr7) (avena sativa pollen - unii:a7iky24tr7), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), pascopyrum smithii pollen (unii: 6au0zd8t1o) (pascopyrum smithii pollen - unii:6au0zd8t1o), felis catus hair (unii: 1564hd0n96) (felis cat - amaranthus retroflexus pollen 0.005 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS346618 injection, solution
TREATMENT SET TS346619 injection, solution
TREATMENT SET TS346620 injection, soluti Bandaríkin - enska - NLM (National Library of Medicine)

treatment set ts346618 injection, solution treatment set ts346619 injection, solution treatment set ts346620 injection, soluti

antigen laboratories, inc. - betula populifolia pollen (unii: 23h70fyj5u) (betula populifolia pollen - unii:23h70fyj5u), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), urtica dioica pollen (unii: dnb59m1nvu) (urtica dioica pollen - unii:dnb59m1nvu), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), periplaneta americana (unii: 2rq1l9n0 - betula populifolia pollen 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski